Jump to content

Albert D. Friesen

From Wikipedia, the free encyclopedia
Albert D. Friesen
Born (1947-05-19) May 19, 1947 (age 77)
Occupation(s)President and CEO
EmployerWinnipeg Rh Institute
Known forWinRho

Albert "Bert" D. Friesen, OM (born May 19, 1947) is a Canadian biotechnologist involved in biotechnology innovation.[1] His biotechnology career began as the first full-time employee of the Winnipeg Rh Institute, where he later became president and CEO, and led the development of WinRho, one of Canada's first successful biotech products.[2]

Career

[edit]

In 1987, Dr. Friesen was a founder and the company’s first board of directors Chairman at the Industrial Biotechnology Association of Canada (IBAC) which is now known as BIOTECanada.[3]

In 1997, Friesen founded Medicure, which sells a large number of cardiovascular products. In 2020, Medicure purchased Marley Drug and the company can now sell medications directly to patients.[3]

References

[edit]
  1. ^ "Local bio-entrepreneur to be honoured". Winnipeg Free Press. 2013-04-22. Retrieved 2016-07-20.
  2. ^ "Manitoba's Bio Builder - Biotechnology FocusBiotechnology Focus | Biotechnology Focus – Leading change in Canada's life science industry, from innovation to business". Biotechnologyfocus.ca. 2013-09-06. Retrieved 2016-07-20.
  3. ^ a b "Albert Friesen | BAM Outstanding Leadership in Bioscience". Medicure Inc. Retrieved 2024-11-15.